- Home
- ERAS vs OFIX Comparison
ERAS vs OFIX Comparison
Compare ERAS & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- OFIX
- Stock Information
- Founded
- ERAS 2018
- OFIX 1987
- Country
- ERAS United States
- OFIX United States
- Employees
- ERAS N/A
- OFIX N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- ERAS Health Care
- OFIX Health Care
- Exchange
- ERAS Nasdaq
- OFIX Nasdaq
- Market Cap
- ERAS 723.8M
- OFIX 722.6M
- IPO Year
- ERAS 2021
- OFIX N/A
- Fundamental
- Price
- ERAS $2.49
- OFIX $17.53
- Analyst Decision
- ERAS Strong Buy
- OFIX Strong Buy
- Analyst Count
- ERAS 5
- OFIX 3
- Target Price
- ERAS $5.90
- OFIX $23.00
- AVG Volume (30 Days)
- ERAS 1.2M
- OFIX 220.1K
- Earning Date
- ERAS 11-12-2024
- OFIX 11-07-2024
- Dividend Yield
- ERAS N/A
- OFIX N/A
- EPS Growth
- ERAS N/A
- OFIX N/A
- EPS
- ERAS N/A
- OFIX N/A
- Revenue
- ERAS N/A
- OFIX $784,249,000.00
- Revenue This Year
- ERAS N/A
- OFIX $8.83
- Revenue Next Year
- ERAS N/A
- OFIX $6.32
- P/E Ratio
- ERAS N/A
- OFIX N/A
- Revenue Growth
- ERAS N/A
- OFIX 17.32
- 52 Week Low
- ERAS $1.64
- OFIX $12.08
- 52 Week High
- ERAS $3.45
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- ERAS 38.71
- OFIX 40.03
- Support Level
- ERAS $2.51
- OFIX $17.68
- Resistance Level
- ERAS $2.68
- OFIX $18.41
- Average True Range (ATR)
- ERAS 0.22
- OFIX 0.58
- MACD
- ERAS -0.05
- OFIX -0.22
- Stochastic Oscillator
- ERAS 10.00
- OFIX 14.17
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.